Agent for Regulating Bone Formation
AssigneeAnGes MG, Inc.
InventorsHideo Shimizu, Hironori Nakagami, Ryuichi Morishita
Life of this patent
Estimating the term…
Loading patent…
AssigneeAnGes MG, Inc.
InventorsHideo Shimizu, Hironori Nakagami, Ryuichi Morishita
Estimating the term…
The present invention provides preventive, ameliorating, and/or therapeutic agents for diseases caused by a disturbed balance between bone formation and bone resorption. The decoys of the present invention induce normal bone metabolism by inhibiting the differentiation-inducing factors of cells involved in bone metabolism. For example, bone resorption can be controlled by using a decoy of the present invention to inhibit NF-κB, a transcriptional regulatory factor that regulates osteoclast differentiation. This method uses a mechanism different from those of previous pharmaceutical agents; therefore, one can expect it to be effective for cases in which existing pharmaceutical agents were not effective.
1-27. (canceled)
A method for modulating bone formation, comprising administering a pharmaceutical composition comprising a bone formation-related transcriptional regulatory factor binding sequence, wherein the sequence is selected from the group consisting of a decoy, an antisense, a ribozyme, an aptamer, and an siRNA.
(canceled)
(canceled)
36-37. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
55-81. (canceled)
Dependencies are inferred from the claim text.